Crossref
Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids
Clinical Thyroidology® · 01.03.2026 · 38 (3) · 92-94
DOI: 10.1177/23299711261436500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Fernanda Vaisman. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vaisman, F. (2026). Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids. Clinical Thyroidology®, 38(3), 92-94. https://doi.org/10.1177/23299711261436500
Vancouver
Vaisman F. Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids. Clinical Thyroidology®. 2026;38(3):92-94. doi:10.1177/23299711261436500
BibTeX
@article{Vaisman2026,
author = {Vaisman, Fernanda},
title = {Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {3},
pages = {92--94},
doi = {10.1177/23299711261436500}
}
EUVIMED